In vivo detection of prion amyloid plaques using [11C]BF-227 PET

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 5, 2010, Pages 934-941

  Okamura, Nobuyuki ^a   Shiga, Yusei ^a   Furumoto, Shozo ^a,b   Tashiro, Manabu ^b   Tsuboi, Yoshio ^c   Furukawa, Katsutoshi ^b   Yanai, Kazuhiko ^a   Iwata, Ren ^b   Arai, Hiroyuki ^b   Kudo, Yukitsuka ^b   Itoyama, Yasuhito ^a   Doh Ura, Katsumi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

Amyloid; Creutzfeldt Jakob disease; PET; Prion

Indexed keywords

2 [2 (2 DIMETHYLAMINOTHIAZOL 5 YL)ETHENYL] 6 [2 (FLUORO)ETHOXY]BENZOXAZOLE C 11; 2 [2 (2 DIMETHYLAMINOTHIAZOL 5 YL)ETHENYL] 6 [2 (FLUORO)ETHOXY]BENZOXAZOLE F 18; PRION PROTEIN; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTORADIOGRAPHY; CEREBELLUM; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DRUG TISSUE LEVEL; EARLY DIAGNOSIS; FEMALE; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGING; IN VIVO STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRION DISEASE; TEMPORAL CORTEX; THALAMUS;

ADULT; AGED; AGED, 80 AND OVER; AUTORADIOGRAPHY; BENZOXAZOLES; BRAIN; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PRION DISEASES; PRIONS; SENILE PLAQUES; THIAZOLES;

EID: 77952090854     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1314-7     Document Type: Article

References (33)

1. DeArmond SJ, Kretzschmar HA, Prusiner SB. Prion diseases. In: Graham DI, Lantos PL, editors. Greenfield's neuropathology, 7th ed. London: Hodder Arnold. p. 273-323.
2. SJ Collins VA Lawson CL Masters 2004 Transmissible spongiform encephalopathies Lancet 363 51 61 10.1016/S0140-6736(03)15171-9 1:CAS:528:DC%2BD2cXos1ah 14723996 (Pubitemid 38076927)
3. S Collins CA McLean CL Masters 2001 Gerstmann-Sträussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies J Clin Neurosci 8 387 397 10.1054/jocn.2001.0919 1:CAS:528:DC%2BD3MXnt12ls7s%3D 11535002 (Pubitemid 32843688)
4. M Noguchi-Shinohara T Hamaguchi T Kitamoto T Sato Y Nakamura H Mizusawa, et al. 2007 Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease Neurology 69 360 367 10.1212/01.wnl.0000266624.63387. 4a 1:STN:280:DC%2BD2svislGrtQ%3D%3D 17646628 (Pubitemid 47205663)
5. CI Lasmézas JP Deslys R Demaimay KT Adjou JJ Hauw D Dormont 1996 Strain specific and common pathogenic events in murine models of scrapie and bovine spongiform encephalopathy J Gen Virol 77 Pt 7 1601 1609 10.1099/0022-1317-77-7-1601 8758005 (Pubitemid 26248677)
6. WJ Schulz-Schaeffer S Tschöke N Kranefuss W Dröse D Hause-Reitner A Giese, et al. 2000 The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases Am J Pathol 156 51 56 1:CAS:528:DC%2BD3cXns1ymug%3D%3D 10623653 (Pubitemid 30644438)
7. JR Fraser 2002 What is the basis of transmissible spongiform encephalopathy induced neurodegeneration and can it be repaired? Neuropathol Appl Neurobiol 28 1 11 10.1046/j.1365-2990.2002.00376.x 1:CAS:528: DC%2BD38XitVKitLc%3D 11849558 (Pubitemid 34175507)
8. GW Small V Kepe LM Ercoli P Siddarth SY Bookheimer KJ Miller, et al. 2006 PET of brain amyloid and tau in mild cognitive impairment N Engl J Med 355 2652 2663 10.1056/NEJMoa054625 1:CAS:528:DC%2BD28XhtlGhtLvL 17182990 (Pubitemid 44969124)
9. WE Klunk H Engler A Nordberg Y Wang G Blomqvist DP Holt, et al. 2004 Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B Ann Neurol 55 306 319 10.1002/ana.20009 1:CAS:528:DC%2BD2cXisFKntb8%3D 14991808 (Pubitemid 38269583)
10. NP Verhoeff AA Wilson S Takeshita L Trop D Hussey K Singh, et al. 2004 In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET Am J Geriatr Psychiatry 12 584 595 15545326 (Pubitemid 41031060)
11. CC Rowe U Ackerman W Browne R Mulligan KL Pike G O'Keefe, et al. 2008 Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism Lancet Neurol 7 129 135 10.1016/S1474-4422(08)70001-2 1:CAS:528:DC%2BD1cXis1WmsLw%3D 18191617
12. Y Kudo N Okamura S Furumoto M Tashiro K Furukawa M Maruyama, et al. 2007 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients J Nucl Med 48 553 561 10.2967/jnumed.106.037556 1:CAS:528:DC%2BD2sXhtVert7nP 17401091 (Pubitemid 47571409)
13. K Ishikawa K Doh-ura Y Kudo N Nishida I Murakami-Kubo Y Ando, et al. 2004 Amyloid imaging probes are useful for detection of prion plaques and treatment of transmissible spongiform encephalopathies J Gen Virol 85 1785 1790 10.1099/vir.0.19754-0 1:CAS:528:DC%2BD2cXltlGhtb4%3D 15166464 (Pubitemid 38807776)
14. M Bresjanac LM Smid TD Vovko A Petric JR Barrio M Popovic 2003 Molecular-imaging probe 2-(1-[6-[(2-fluoroethyl)(methyl) amino]-2-naphthyl] ethylidene) malononitrile labels prion plaques in vitro J Neurosci 23 8029 8033 1:CAS:528:DC%2BD3sXnt1WqtL4%3D 12954864 (Pubitemid 37082455)
15. M Sadowski J Pankiewicz H Scholtzova J Tsai Y Li RI Carp, et al. 2004 Targeting prion amyloid deposits in vivo J Neuropathol Exp Neurol 63 775 784 1:CAS:528:DC%2BD2cXmtFGgsr4%3D 15290902 (Pubitemid 38891093)
16. VB Hoefert JM Aiken D McKenzie CJ Johnson 2004 Labeling of the scrapie-associated prion protein in vitro and in vivo Neurosci Lett 371 176 180 10.1016/j.neulet.2004.08.065 1:CAS:528:DC%2BD2cXptFOrsrc%3D 15519752 (Pubitemid 39440766)
17. AL Boxer GD Rabinovici V Kepe J Goldman AJ Furst SC Huang, et al. 2007 Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease Neurology 69 283 290 10.1212/01.wnl.0000265815.38958.b6 1:STN:280: DC%2BD2svhvFSquw%3D%3D 17636066 (Pubitemid 47205691)
18. VL Villemagne CA McLean K Reardon A Boyd V Lewis G Klug, et al. 2009 11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease J Neurol Neurosurg Psychiatry 80 998 1001 10.1136/jnnp.2008.171496 10.1136/jnnp.2008. 171496 1:STN:280:DC%2BD1MrlsV2rsA%3D%3D 19332421
19. N Okamura T Suemoto H Shimadzu M Suzuki T Shiomitsu H Akatsu, et al. 2004 Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain J Neurosci 24 2535 2541 10.1523/JNEUROSCI.4456-03.2004 1:CAS:528:DC%2BD2cXisVKhtr8%3D 15014129 (Pubitemid 38327966)
20. K Ishikawa Y Kudo N Nishida T Suemoto T Sawada T Iwaki, et al. 2006 Styrylbenzoazole derivatives for imaging of prion plaques and treatment of transmissible spongiform encephalopathies J Neurochem 99 198 205 10.1111/j.1471-4159.2006.04035.x 1:CAS:528:DC%2BD28XhtFGhtrnF 16987247 (Pubitemid 44395142)
21. M Waragai N Okamura K Furukawa M Tashiro S Furumoto Y Funaki, et al. 2009 Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease J Neurol Sci 285 100 108 10.1016/j.jns.2009.06.005 10.1016/j.jns.2009.06.005 19552926
22. N Okamura S Furumoto Y Funaki T Suemoto M Kato Y Ishikawa, et al. 2007 Binding and safety profile of novel benzoxazole derivative for in vivo imaging of amyloid deposits in Alzheimer's disease Geriatr Gerontol Int 7 393 400 10.1111/j.1447-0594.2007.00389.x
23. Zeidler M, Gibbs CJ Jr, Meslin F. WHO manual for strengthening diagnosis and surveillance of Creutzfeldt-Jakob disease. Geneva: World Health Organization; 1998. p. 47-51.
24. G McKhann D Drachman M Folstein R Katzman D Price EM Stadlan 1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 939 944 1:STN:280:DyaL2c3ks1altQ%3D%3D 6610841 (Pubitemid 14076461)
25. KJ Friston AP Holmes KJ Worsley JP Poline CD Frith RSJ Frackowiack 1995 Statistical parametric maps in functional imaging: a general linear approach Hum Brain Mapp 2 189 210 10.1002/hbm.460020402
26. CL Masters DC Gajdusek CJ Gibbs Jr 1981 Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies Brain 104 559 588 10.1093/brain/104.3.559 1:STN:280: DyaL38%2FgtFeruw%3D%3D 6791762
27. JW Ironside L McCardle A Horsburgh Z Lim MW Head 2002 Pathological diagnosis of variant Creutzfeldt-Jakob disease APMIS 110 79 87 10.1034/j.1600-0463.2002.100110.x 1:CAS:528:DC%2BD38Xjs1Gqtrc%3D 12064259 (Pubitemid 34289472)
28. AF Hill M Zeidler J Ironside J Collinge 1997 Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy Lancet 349 99 100 10.1016/S0140-6736(97)24002-X 1:STN:280:DyaK2s7kvFKitA%3D%3D 8996424 (Pubitemid 27023429)
29. K Doh-ura K Ishikawa I Murakami-Kubo K Sasaki S Mohri R Race T Iwaki 2004 Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models J Virol 78 4999 5006 10.1128/JVI.78.10.4999-5006.2004 1:CAS:528:DC%2BD2cXjvFeqsr0%3D 15113880 (Pubitemid 38581450)
30. NG Rainov Y Tsuboi P Krolak-Salmon A Vighetto K Doh-Ura 2007 Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate? Expert Opin Biol Ther 7 713 726 10.1517/14712598.7.5. 713 1:CAS:528:DC%2BD2sXkvVCisLo%3D 17477808 (Pubitemid 46707192)
31. A De Luigi L Colombo L Diomede R Capobianco M Mangieri C Miccolo L Limido G Forloni F Tagliavini M Salmona 2008 The efficacy of tetracyclines in peripheral and intracerebral prion infection PLoS One 3 e1888 10.1371/journal.pone.0001888 18365024 (Pubitemid 351943730)
32. K Teruya K Kawagoe T Kimura CJ Chen Y Sakasegawa K Doh-ura 2009 Amyloidophilic compounds for prion diseases Infect Disord Drug Targets 9 15 22 1:CAS:528:DC%2BD1MXkvVSmtro%3D 19200011
33. G Forloni M Salmona G Marcon F Tagliavini 2009 Tetracyclines and prion infectivity Infect Disord Drug Targets 9 23 30 1:CAS:528:DC%2BD1MXkvVSmtrs%3D 19200012